GlassScriptPhysician profile
Rasa Zarnegar
NPI 1194781534
$478,137.79
in general payments reported to CMS, 2019-2025
15 companies · $185K in 2025
The $185K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $39K · 2021: $22K · 2022: $12K · 2023: $50K · 2024: $128K · 2025: $185K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $244K · Travel and Lodging: $51K · Education: $28K · Consulting Fee: $22K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $243,925.00 |
| Travel and Lodging | $51,259.33 |
| Education | $27,750.00 |
| Consulting Fee | $21,730.00 |
| Food and Beverage | $10,714.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $397,058.13 | 2019-2025 | Phasix Mesh, Channel Drain, Bard 3dmax Mesh |
| Intuitive Surgical, INC. | $45,824.74 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $29,930.73 | 2021-2025 | Ligasure |
| Conmed Corporation | $3,047.22 | 2024 | Airseal |
| Becton, Dickinson and Company | $828.72 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $381.05 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $278.29 | 2019 | |
| Corcept Therapeutics | $275.04 | 2021-2022 | |
| Checkpoint Surgical, INC | $179.57 | 2022 | |
| Cipla USA INC. | $100.00 | 2019 | |
| Neuropace, INC. | $79.83 | 2019 | |
| Bard Peripheral Vascular, INC. | $55.20 | 2024 | Phasix Mesh |
| Integra Lifesciences Corporation | $51.44 | 2024-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Laborie Medical Technologies Corp. | $25.10 | 2024 | Alphaone |
| Medical Device Business Services, INC. | $22.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rasa Zarnegar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.